To evaluate the role of microdebrider in patients undergoing endoscopic adenoidectomy. Prospective interventional study. Tertiary referral hospital. Twenty patients requiring adenoidectomy were included in the study. Mean operative time was found to be 31.5 min. Mean blood loss was 29.45 ml. All the patients had complete removal of adenoid mass. None of the patients had any kind of collateral damage. It gives a complete clearance of obstructive adenoids under vision thus providing reliable restoration of nasopharyngeal patency.

Background: Ischemic heart disease (IHD) remains a leading cause of mortality in the United States, while arrhythmia‐related deaths are increasing. However, long‐term mortality trends involving both conditions remain unclear. Methods: We utilized the CDC WONDER Multiple Cause‐of‐Death database to obtain records from 1999 to 2023, targeting US adults aged ≥ 25 years. Deaths involving IHD and arrhythmias were assessed. Age‐adjusted mortality rates (AAMR) were calculated and stratified by gender, age, ethnicity, census region, and urbanization. Results: A total of 1 795 918 deaths were attributed to both IHD and cardiac arrhythmias between 1999 and 2023. The AAMR declined from 41.97 (95% CI: 41.66−42.27) in 1999 to 32.73 (95% CI: 32.51−32.94) in 2023, representing an overall decrease of 22% (AAPC −0.99). Men had higher AAMRs compared to women (45.0 [95% CI: 44.6−45.5] vs. 23.4 [95% CI: 23.2−23.7]). The highest mortality rate was observed among NH White individuals (AAMR: 34.8; 95% CI: 34.5−35.0), while the lowest was among NH Asian or Pacific Islanders (AAMR: 16.5; 95% CI: 15.6−17.5). Older adults exhibited the higher AAMRs (144.74; 95% CI: 143.60−145.88) compared to younger cohorts. An increased death burden was observed in non‐metropolitan (AAMR: 37.1; 95% CI: 36.5−37.8) and Midwest regions (35.5; 95% CI: 34.9−36.0). The majority of the deaths occurred in inpatient facilities (34.7%). Conclusions: Although IHD–arrhythmia mortality declined between 1999 and 2023, substantial disparities persisted across demographic and geographic subgroups, highlighting the need for targeted public health interventions.

Background: Acute respiratory distress syndrome (ARDS) secondary to sepsis remains a life-threatening condition despite advances in critical care. Population-based trends in sepsis-associated ARDS mortality across the U.S. are not well studied. This study examines mortality trends among adults from 1999 to 2023, focusing on demographic and geographic differences. Methods: This retrospective study utilized the CDC WONDER database as the Source for Multiple Cause of Death. Death certificates were retrieved for Sepsis-related ARDS from 1999 to 2023 among adults ≥25 years. Age-adjusted mortality rates (AAMR) per 100,000 population were calculated, and the annual percentage change (APC) was assessed using Joinpoint regression. Trends were stratified by year, sex, race/ethnicity, and region. Results: A total of 87,745 deaths were recorded. AAMR declined from 1.92 in 1999 to 1.22 in 2006 (APC = − 6.39%), remained stable through 2018, rose sharply to 3.87 in 2021 (APC = + 42.74%), then fell to 1.30 in 2023 (APC = − 42.70%). Rates were higher in males than in females (AAMR: 1.81 vs. 1.37), with males peaking more steeply during 2018–2021 (APC = + 49.08% vs. + 31.40%), and in older adults (CDR: 4.74). By race, Non-Hispanic (NH) American Indian/Alaska Native had the highest AAMR (2.57), followed by NH Black (2.15) and Hispanic (2.03). Hispanics experienced the steepest pandemic-era spike (6.92 in 2021; APC = + 78.53%), followed by a subsequent decline (APC = − 58.44%). Regionally, the South had the highest mortality (1.77), and nonmetropolitan areas exceeded metropolitan (1.59 vs. 1.45). Conclusion: Sepsis-associated ARDS mortality declined from 1999 to 2020 but surged during the pandemic before falling again. Persistent disparities by sex, age, race/ethnicity, and geography highlight the need for targeted prevention, earlier detection, and equitable critical care.